mGem:细菌菌体的免疫识别和清除 - - 对于菌体治疗的含义
H T Le1,2, G Ahlenstiel1,2,3, C Venturini4,5
1Blacktown Clinical School, Western Sydney University, Sydney, New South Wales, Australia.
mBio
|November 5, 2025
概括
菌体显示出治疗感染的希望,但免疫系统很快就会去除它们. 开发免疫学伪装的菌体是针对耐药细菌的有效菌体治疗的关键.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 菌体 (菌体) 是感染细菌的病毒,正在作为向抗菌疗法进行探索.
- 菌体治疗的有效性受到菌体从循环中迅速免疫清除的限制.
- 这种免疫反应需要开发策略来增强菌体在生物体内的持续性.
研究的目的:
- 为了应对治疗性细菌菌体的快速免疫清除的挑战.
- 探索开发第二代和第三代菌体疗法的方法.
- 通过逃避宿主免疫反应来提高菌体治疗的疗效.
主要方法:
- 调查与免疫逃避相关的细菌体 (体) 特性.
- 开发分离或修改菌体以减少免疫原性方法.
- 评估修改菌体的治疗潜力和免疫学概况.
主要成果:
- 主体免疫系统在几个小时内迅速清除注射的菌体的99%.
- 天生的和适应性免疫反应有助于治疗性菌体的快速清除和破坏.
- 有效的菌体治疗需要免疫伪装策略.
结论:
- 克服快速免疫清除对于菌体治疗的成功临床应用至关重要.
- 免疫隐形菌体的开发将导致更有效的抗菌治疗.
- 第二代和第三代菌体疗法在针对多药耐药性感染方面具有前景.
相关概念视频
Bacteriophages of the Human Virome
Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...
Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...
Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...


